Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/j.jalz.2011.03.005 | The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease |
| https://doi.org/10.1016/j.jalz.2011.03.008 | The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease |
| https://doi.org/10.1016/j.jalz.2018.02.018 | NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease |
| https://doi.org/10.1016/j.jalz.2011.03.003 | Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease |
| https://doi.org/10.1016/j.jalz.2011.10.007 | National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease |
| https://doi.org/10.1016/j.jalz.2011.03.004 | Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease |
| https://doi.org/10.1016/j.jalz.2016.02.002 | Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria |
| https://doi.org/10.1002/alz.13859 | Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup |
| https://doi.org/10.1212/wnl.0000000000002923 | A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers |
| https://doi.org/10.1016/j.jalz.2015.05.016 | Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective |
| https://doi.org/10.1001/jama.2015.4668 | Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia |
| https://doi.org/10.1001/jama.2020.12134 | Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders |
| https://doi.org/10.1038/ncomms11934 | Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis |
| https://doi.org/10.1016/j.jalz.2011.05.2410 | Neuropsychiatric symptoms in Alzheimer's disease |
| https://doi.org/10.1159/000316119 | Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy |
| https://doi.org/10.1016/j.jalz.2011.05.2351 | Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup |
| https://doi.org/10.1073/pnas.0900345106 | Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease |
| https://doi.org/10.1016/j.neurobiolaging.2009.07.002 | Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI |
| https://doi.org/10.1016/j.neuron.2018.05.023 | Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus |
| https://doi.org/10.1056/nejmoa1706441 | Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease |
| https://doi.org/10.1001/jama.2015.4669 | Prevalence of Amyloid PET Positivity in Dementia Syndromes |
| https://doi.org/10.1016/j.jalz.2017.01.014 | Consensus classification of posterior cortical atrophy |
| https://doi.org/10.1001/jama.2019.2000 | Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia |
| https://doi.org/10.1093/geront/gnx122 | The Fundamentals of Person-Centered Care for Individuals With Dementia |
| https://doi.org/10.1016/s1474-4422(20)30440-3 | New insights into atypical Alzheimer's disease in the era of biomarkers |
| https://doi.org/10.1016/s1474-4422(17)30159-x | Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers |
| https://doi.org/10.1016/j.jalz.2014.10.008 | Vascular contributions to cognitive impairment and dementia including Alzheimer's disease |
| https://doi.org/10.1038/ng.536 | Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions |
| https://doi.org/10.1073/pnas.0709259105 | Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons |
| https://doi.org/10.1016/j.jalz.2013.01.002 | Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association |
| https://doi.org/10.1038/s41591-019-0611-3 | Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report |
| https://doi.org/10.1016/j.jalz.2012.09.011 | Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting |
| https://doi.org/10.1002/alz.12756 | The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease |
| https://doi.org/10.1056/nejmoa1812840 | Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease |
| https://doi.org/10.1016/s1474-4422(12)70228-4 | Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study |
| https://doi.org/10.1016/j.jalz.2010.03.003 | The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core |
| https://doi.org/10.1016/j.jalz.2018.09.009 | Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need |
| https://doi.org/10.1038/s41467-020-15701-2 | Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease |
| https://doi.org/10.1016/s1474-4422(20)30314-8 | Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias |
| https://doi.org/10.1002/alz.12123 | World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia |
| https://doi.org/10.1038/ng.2007.16 | A survey of genetic human cortical gene expression |
| https://doi.org/10.1016/j.neuron.2007.05.022 | GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers |
| https://doi.org/10.1038/s41467-019-14279-8 | Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study |
| https://doi.org/10.1097/01.jgp.0000240986.74642.7c | Vitamin D Deficiency Is Associated With Low Mood and Worse Cognitive Performance in Older Adults |
| https://doi.org/10.1038/s41366-018-0120-3 | Genome-wide association study of habitual physical activity in over 377,000 UK Biobank participants identifies multiple variants including CADM2 and APOE |
| https://doi.org/10.1016/j.trci.2019.02.001 | White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities |
| https://doi.org/10.1001/jamaneurol.2020.0528 | Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes |
| https://doi.org/10.1038/s41586-024-07185-7 | APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia |
| https://doi.org/10.1016/j.jalz.2011.05.2243 | The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers |
| https://doi.org/10.1016/j.jalz.2010.11.007 | National estimates of the prevalence of Alzheimer's disease in the United States |
| https://doi.org/10.1001/jama.2016.8655 | Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease |
| https://doi.org/10.1038/s41598-018-37769-z | Predicting Alzheimer’s disease progression using multi-modal deep learning approach |
| https://doi.org/10.1016/s1474-4422(16)30235-6 | Research priorities to reduce the global burden of dementia by 2025 |
| https://doi.org/10.1016/j.jalz.2013.01.010 | CSF biomarker variability in the Alzheimer's Association quality control program |
| https://doi.org/10.1016/j.trci.2017.07.001 | Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms |
| https://doi.org/10.1371/journal.pgen.1004606 | Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias |
| https://doi.org/10.2967/jnumed.114.148981 | Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios |
| https://doi.org/10.1016/j.jagp.2017.09.006 | A Systematic Review of Dementia-related Stigma Research: Can We Move the Stigma Dial? |
| https://doi.org/10.1038/ncomms13249 | Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology |
| https://doi.org/10.1038/s41467-019-14159-1 | Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease |
| https://doi.org/10.3233/jad-2011-0059 | Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments |
| https://doi.org/10.1152/physiolgenomics.00208.2006 | Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain |
| https://doi.org/10.2967/jnumed.113.120618 | Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association |
| https://doi.org/10.1038/ncomms7760 | Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE |
| https://doi.org/10.1016/j.jamda.2015.06.017 | Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference |
| https://doi.org/10.1016/j.ajhg.2009.03.011 | Genetic Control of Human Brain Transcript Expression in Alzheimer Disease |
| https://doi.org/10.1038/mp.2015.23 | A novel Alzheimer disease locus located near the gene encoding tau protein |
| https://doi.org/10.1152/physiolgenomics.00242.2007 | Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set |
| https://doi.org/10.1002/gps.3790 | A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity |
| https://doi.org/10.1016/j.jalz.2014.10.007 | Down syndrome and Alzheimer's disease: Common pathways, common goals |
| https://doi.org/10.1093/geront/45.suppl_1.96 | Attitudes, Stress, and Satisfaction of Staff Who Care for Residents With Dementia |
| https://doi.org/10.1016/j.maturitas.2016.01.015 | Modeling menopause: The utility of rodents in translational behavioral endocrinology research |
| https://doi.org/10.1016/j.jalz.2014.08.099 | Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research |
| https://doi.org/10.1016/j.neuroimage.2008.12.072 | Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) |
| https://doi.org/10.1001/jamaneurol.2021.5216 | Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum |
| https://doi.org/10.1001/jamaneurol.2013.4544 | Brain Differences in Infants at Differential Genetic Risk for Late-Onset Alzheimer Disease |
| https://doi.org/10.1016/j.jalz.2016.08.004 | Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative |
| https://doi.org/10.1016/j.jalz.2018.07.220 | Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease |
| https://doi.org/10.1080/13607860801933323 | Perceived stress and resilience in Alzheimer's disease caregivers: Testing moderation and mediation models of social support |
| https://doi.org/10.1093/hmg/ddq221 | Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals |
| https://doi.org/10.1093/geronb/gbn041 | Neighborhood-Level Cohesion and Disorder: Measurement and Validation in Two Older Adult Urban Populations |
| https://doi.org/10.1016/s1474-4422(12)70227-2 | Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study |
| https://doi.org/10.1016/j.trci.2016.05.001 | The roles of inflammation and immune mechanisms in Alzheimer's disease |
| https://doi.org/10.1002/alz.12510 | Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group |
| https://doi.org/10.1212/wnl.0b013e3182661f74 | Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline |
| https://doi.org/10.4088/jcp.v69n0602 | Elderly Patients With Dementia-Related Symptoms of Severe Agitation and Aggression |
| https://doi.org/10.1016/j.tins.2017.05.001 | Adaptive Capacity: An Evolutionary Neuroscience Model Linking Exercise, Cognition, and Brain Health |
| https://doi.org/10.1016/j.neurobiolaging.2014.09.027 | Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes |
| https://doi.org/10.1093/geront/gnx182 | Alzheimer’s Association Dementia Care Practice Recommendations |
| https://doi.org/10.1002/alz.12157 | Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop |
| https://doi.org/10.1212/wnl.0000000000004171 | Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults |
| https://doi.org/10.1017/s1041610200006360 | Coping With Dementia: Evaluation of Four Nonpharmacologic Interventions |
| https://doi.org/10.1056/nejmoa1900757 | Tau Positron-Emission Tomography in Former National Football League Players |
| https://doi.org/10.1016/j.neurobiolaging.2012.04.017 | Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease |
| https://doi.org/10.1016/j.jalz.2016.12.012 | Transethnic genome‐wide scan identifies novel Alzheimer's disease loci |
| https://doi.org/10.1001/jama.2015.10214 | Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia |
| https://doi.org/10.2147/vhrm.s34874 | Cerebral blood flow in Alzheimer’s disease |
| https://doi.org/10.1002/alz.12255 | The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning |
| https://doi.org/10.1136/bmjopen-2017-019223 | Systematic review of prediction models for delirium in the older adult inpatient |
| https://doi.org/10.1002/ana.25333 | Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia |